Pages that link to "Q46687438"
Jump to navigation
Jump to search
The following pages link to Novel immunosuppression: R348, a JAK3- and Syk-inhibitor attenuates acute cardiac allograft rejection (Q46687438):
Displaying 13 items.
- NSC114792, a novel small molecule identified through structure-based computational database screening, selectively inhibits JAK3 (Q33530722) (← links)
- Cross-Reactivity Virtual Profiling of the Human Kinome by X-ReactKIN: A Chemical Systems Biology Approach (Q34384664) (← links)
- BD750, a benzothiazole derivative, inhibits T cell proliferation by affecting the JAK3/STAT5 signalling pathway (Q36629277) (← links)
- Kinase inhibitors for the treatment of inflammatory and autoimmune disorders (Q37196300) (← links)
- Pharmacological control of receptor of advanced glycation end-products and its biological effects in psoriasis (Q37258222) (← links)
- Perspectives for the use of structural information and chemical genetics to develop inhibitors of Janus kinases (Q37687519) (← links)
- Recent patents in the discovery of small molecule inhibitors of JAK3. (Q37733546) (← links)
- Targeting non-malignant disorders with tyrosine kinase inhibitors. (Q37814085) (← links)
- Systems biology analysis of protein-drug interactions. (Q37972867) (← links)
- Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice (Q43274291) (← links)
- Prevention of chronic renal allograft rejection by AS2553627, a novel JAK inhibitor, in a rat transplantation model (Q47680604) (← links)
- A New Concept of the Old Inhibitor NSC 74859 in Alleviating Cardiac Allograft Rejection and Extending Allograft Survival in Mice. (Q50220279) (← links)
- Emerging drugs for psoriasis (Q57244448) (← links)